Following eligibility assessment based on predefined inclusion criteria, that is, relevance to cellular senescence mechanisms, therapeutic targeting (senolytics or senomorphics), and availability of clear mechanistic or clinical outcome data, 261 peer-reviewed articles were finally included in this review
Although GLP-1 receptor agonists are generally well tolerated in metabolic populations, they are associated with potential side effects such as gastrointestinal discomfort, nausea, and appetite changes
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L
These findings suggest that tirzepatide confers cardiovascular benefits at least comparable to established GLP-1RAs
Retrieved from Goyal, R
Additionally, GLP-1 therapies are gaining recognition as a novel approach to Alzheimers disease due to their anti-inflammatory and neuroprotective characteristics